Next 10 |
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXTQ), a pharmaceutical company dedicated to providing solutions to un...
Clarus Therapeutics ( OTCPK:CRXT ) filed voluntary petitions under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware and want to pursue an auction and sale of its only commercial asset Jatenzo. Jatenzo is approved to treat testosterone deficiency i...
NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen therapies, announced today that it, together with its wholly-owned subsidiary ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: madamF / Shutterstock.com Pinduoduo (NASDAQ: PDD ) stock is getting a boost on Monday after the Chinese agriculture tech company released results for the second quarter of 2022 . The positive earnings...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: JJava Designs / Shutterstock Fans of AMC Entertainment (NYSE: AMC ) stock will want to keep an eye on the company come Sept. 3 as it prepares for a special theater event . AMC Entertainment, alongside...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: shutterstock.com/PhotobyTawat Humanigen (NASDAQ: HGEN ) stock is heading lower on Monday as investors react to a delisting notice from the Nasdaq Exchange . According to a filing with the U.S. Secur...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: arfa adam / Shutterstock.com Clarus Therapeutics (NASDAQ: CRXT ) stock is falling hard on Monday as investors prepare for the stock to be delisted later this week . Shares of CRXT stock will no longer...
Which penny stocks are at the top of your list today? If you’ve seen some of the biggest gapping stocks of the day, you’ll see several that we’ve discussed right here on PennyStocks.com have exploded over the last few sessions. Companies like Bright Minds Biosciences ( ...
Clarus Therapeutics press release ( NASDAQ: CRXT ): Q2 GAAP EPS of -$0.24 beats by $0.06 . Revenue of $4.05M (+45.7% Y/Y) misses by $0.92M . Shares -4.31% . For further details see: Clarus Therapeutics GAAP EPS of -$0.24 beats by $0.06, revenue of...
Second quarter 2022 net revenue increased 46% year-over-year to $4.1 million Second quarter 2022 total prescription growth for JATENZO® increased 23% sequentially and increased 72% year-over-year Immediate reduction in workforce by approximately 40% of total headcou...
News, Short Squeeze, Breakout and More Instantly...
Clarus Therapeutics Holdings Inc. Company Name:
CRXT Stock Symbol:
NASDAQ Market:
Court-supervised auction for JATENZO (testosterone undecanoate capsules; C-III) concluded on October 14, 2022 NORTHBROOK, Ill., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXTQ), a pharmaceutical company dedicated to providing solutions to un...
NORTHBROOK, Ill., Sept. 05, 2022 (GLOBE NEWSWIRE) -- Clarus Therapeutics Holdings, Inc. (Clarus) (OTC: CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen therapies, announced today that it, together with its wholly-owned subsidiary ...